Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 61Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 12Carcinoma, Non-Small-Cell Lung 8Neoplasms 4Lung Neoplasms 4Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Recurrent Squamous Cell Lung Carcinoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Kidney Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Sunitinib 17Sorafenib 16pazopanib 7cabozantinib 7Axitinib 7Blood Specimen Collection 6Bevacizumab 6avelumab 5Immunohistochemistry 5temsirolimus 4pembrolizumab 3Watchful Waiting 3Specimen Handling 3Immunotherapy 3Gene Expression Profiling 3Everolimus 3Urine Specimen Collection 2Nephrectomy 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Flow Cytometry 2Data Collection 2Amplified Fragment Length Polymorphism Analysis 2trastuzumab deruxtecan 1lenvatinib 1fluoroazomycin arabinoside 1enfortumab vedotin 1darolutamide 1atezolizumab 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Renal Cell × Ipilimumab × Clear all
NCT05287464 2025-11-26

International Multicentric Study ARON-1

Hospital of Macerata

Recruiting
1,220 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡